Alirocumab after Acute Coronary Syndrome

N Engl J Med. 2019 May 23;380(21):2075-2076. doi: 10.1056/NEJMc1902955.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Acute Coronary Syndrome*
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Humans
  • Proprotein Convertase 9

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Proprotein Convertase 9
  • alirocumab